Home > Healthcare > Medical Devices > Diagnostic Devices > Automated Visual Field Analyzer Market

Automated Visual Field Analyzer Market Trends

  • Report ID: GMI12826
  • Published Date: Dec 2024
  • Report Format: PDF

Automated Visual Field Analyzer Market Trends

The rising prevalence of glaucoma and other eye disorders is a significant driver for the market. Glaucoma, often referred to as the silent thief of sight, is one of the leading causes of irreversible blindness globally. According to Opthalmology Journal, in 2013, the number of people (aged 40-80 years) with glaucoma worldwide was estimated to be 64.3 million, increasing to 76 million in 2020 and 111.8 million in 2040.
 

  • This condition, characterized by progressive optic nerve damage and vision loss, necessitates early and accurate diagnosis to prevent permanent visual impairment. Automated visual field analyzers play a critical role in detecting visual field defects caused by glaucoma at early stages, making them indispensable tools in ophthalmology.
     
  • Moreover, the increasing incidence of other eye disorders such as age-related macular degeneration (AMD), and cataracts further fuels demand. These conditions require regular monitoring of visual field changes to guide treatment decisions effectively. For instance, according to International Agency for the Prevention of Blindness, approximately 5% of blindness globally is due to AMD. It is estimated that globally 196 million people have AMD in 2020, increasing to 288 million in 2040. The rise in these disorders is driven by factors such as aging populations, lifestyle changes, and the increasing burden of chronic diseases like diabetes.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global automated visual field analyzer industry was valued at USD 231.4 million in 2024 and is projected to grow at a 5.8% CAGR from 2025 to 2034, driven by technological advancements and increasing awareness of early diagnosis.

The static segment is expected to grow at a 5.5% CAGR, reaching over USD 276.1 million by 2034, as it provides precise and repeatable results critical for detecting early signs of visual field loss, particularly in glaucoma patients.

The U.S. automated visual field analyzer market was valued at USD 76.9 million in 2024 and is anticipated to grow at a 4.8% CAGR from 2025 to 2034, driven by the rising prevalence of eye disorders such as glaucoma and diabetic retinopathy.

Key players in the market include Canon, ESSILOR INSTRUMENTS, HAAG-STREIT GROUP, HEIDELBERG ENGINEERING, Konan Medical, Kowa, MEDA, Metrovision, OCULUS, Optopol, Reichert AMETEK, Rexxam, and TOPCON Healthcare.

Automated Visual Field Analyzer Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 14
  • Tables & Figures: 135
  • Countries covered: 19
  • Pages: 120
 Download Free Sample